Related Experiment Video
Updated: Aug 20, 2025
06:41
A New Technique for Quantitative Analysis of Hair Loss in Mice Using Grayscale Analysis
Published on: March 9, 2015
9.0K
Resistant Alopecia Areata Treated with Tofacitinib
1Skinvel Hair and Skin Clinic, Jaipur, Rajasthan, India.
International Journal of Trichology
|November 21, 2022
Summary
Tofacitinib effectively treated a young adult male with resistant alopecia areata (AA) after other therapies failed. Significant hair regrowth was observed within months, with no reported side effects.
Area of Science:
- Dermatology
- Immunology
- Pharmacology
Background:
- Alopecia areata (AA) is an autoimmune condition causing hair loss.
- Treatment resistance is common in severe AA cases.
- Tofacitinib, a Janus kinase inhibitor, has shown promise for AA in previous reports.
Observation:
- A young adult male with treatment-resistant AA was studied.
- Previous treatments included steroids, minoxidil, and troxalene.
- The patient received tofacitinib 5 mg twice daily with biotin.
Findings:
- Visible hair regrowth occurred within one month of treatment.
- Over 90% hair regrowth was achieved after three months.
- No adverse side effects were documented during the treatment period.
Implications:
- Tofacitinib represents a potential therapeutic option for resistant alopecia areata.
- This case highlights the efficacy of JAK inhibitors in managing severe AA.
- Further research into tofacitinib for AA is warranted to confirm safety and efficacy.
Related Concept Videos
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
248
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
248
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
211
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
211
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
188
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
188
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
01:27Tumor Immunotherapy
631
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
631